As expression of some miRNAs in the miR-17∼92 cluster and its paralogs is upregulated in prostate cancer patients (47), miR-17 targeting TIMP3, p21 and PTEN appears to be a crucial event in prostate cancer development and invasion. This evidence concerns the gene CDKN1A and prostate carcinoma.